Spyre Therapeutics, Inc. · NASDAQ:SYRE

Burrows Scott L sold 7,500 Spyre Therapeutics, Inc. shares (Form 4)

Traded Apr 1, 2026 · Filed Apr 3, 2026

On Apr 1, 2026, Burrows Scott L (Chief Financial Officer) sold 7,500 Spyre Therapeutics, Inc. shares at an average US$49.34 for US$370K under a trading plan, leaving 97,994 shares. Filed Apr 3, 2026 (Form 4).

Sold
7,500 shares
Price
US$49.34 average (US$49.21 to US$49.98)
Value
US$370K
Holding after
97,994 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Common StockOption exercise7,500US$14.50105,494Direct
Apr 1, 2026Common StockSale6,200US$49.2199,294Direct
Apr 1, 2026Common StockSale1,300US$49.9897,994Direct

Source

View original at SEC

Related